HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Refractory Hyperlactatemia with Organ Insufficiency in Lipid Storage Myopathy.

Abstract
Lipid storage myopathy is a metabolic disorder characterized by abnormal lipid accumulation in muscle fibers and progressive muscle weakness. Here, we report the case of a 17-year-old woman with progressive muscle weakness, refractory hyperlactatemia, and multiple organ insufficiency. Severe pneumonia was the initial diagnosis. After anti-infective treatment, fluid resuscitation, and mechanical ventilation, the patient's symptoms improved but hyperlactatemia and muscle weakness persisted. She was empirically treated with carnitine. Biochemical tests, electromyography, and muscle biopsy confirmed lipid storage myopathy. After 7 weeks of treatment, the patient resumed normal daily life. An empirical treatment with carnitine may be beneficial for patients before an accurate diagnosis of lipid storage myopathy is made.
AuthorsYuanda Xu, Li Zhou, Weibo Liang, Weiqun He, Xiaoqing Liu, Xiuling Liang, Nanshan Zhong, Yimin Li
JournalArchives of Iranian medicine (Arch Iran Med) Vol. 18 Issue 8 Pg. 545-8 (Aug 2015) ISSN: 1735-3947 [Electronic] Iran
PMID26265524 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Carnitine
Topics
  • Adolescent
  • Bronchitis (etiology)
  • Carnitine (therapeutic use)
  • Female
  • Humans
  • Hyperlactatemia (etiology)
  • Lipid Metabolism, Inborn Errors (diagnosis, drug therapy)
  • Muscle Weakness (etiology)
  • Muscular Dystrophies (diagnosis, drug therapy)
  • Pneumonia (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: